BridgeMD
New treatment option for Chronic Obstructive Pulmonary Disease (COPD)
Official title Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma
ClinicalTrials.gov ID: NCT07183657
What this study is testing
- What it's testing
- Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- PATIENTS
- signed informed consent,
- age ≥ 18 years,
- previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,
- ability to cooperate,
You likely can't join if
- pre-terminal/terminal stage of any disease,
- uncooperative patient,
- significant limitation of mobility or cognitive functions. HEALTHCARE PROFESSIONALS Inclusion Criteria:
- signed informed consent,
- completed education in medicine, pharmacy, or nursing,
- more than one year of working experience,
See the full eligibility criteria
- PATIENTS
- signed informed consent,
- age ≥ 18 years,
- previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,
- ability to cooperate,
- at least 8 weeks without exacerbation,
- use of a particular inhaler for at least 3 months.
- pre-terminal/terminal stage of any disease,
- uncooperative patient,
- significant limitation of mobility or cognitive functions. HEALTHCARE PROFESSIONALS Inclusion Criteria:
- signed informed consent,
- completed education in medicine, pharmacy, or nursing,
- more than one year of working experience,
- care for patients taking inhaled therapy for BA/COPD.
The study team makes the final eligibility decision.
Where it's taking place
- Hradec Králové, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hradec Králové, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.